Page last updated: 2024-08-22

mitomycin a and Pseudomyxoma Peritonei

mitomycin a has been researched along with Pseudomyxoma Peritonei in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chua, TC; Liauw, W; Morris, DL; Zhao, J1

Other Studies

1 other study(ies) available for mitomycin a and Pseudomyxoma Peritonei

ArticleYear
Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate.
    Annals of surgery, 2011, Volume: 253, Issue:4

    Topics: Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Chi-Square Distribution; Cohort Studies; Combined Modality Therapy; Female; Humans; Infusions, Parenteral; Kaplan-Meier Estimate; Laparotomy; Male; Mitomycins; Neoplasm Recurrence, Local; Neoplasm Staging; Perioperative Care; Peritoneal Neoplasms; Peritoneum; Postoperative Complications; Prognosis; Pseudomyxoma Peritonei; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Survival Analysis; Treatment Outcome

2011